Home | About Us | Services | Recent Publications | Toxin Tales | Contact Us

Toxin Tales

An interesting headache?

At a recent congress I attended, there was a very clear and concise presentation on the use of BoNT-A in migraine/headache.  All the facts and figures were there about the studies performed, especially the US PREEMPT package that gave the basis for licensing of chronic daily migraine by the FDA.  There were, however, a number of items “missing” from what was presented - especially data that should have been emphasised or clarified more.

But perhaps the most extraordinary part came at question time.  The presenter was asked why patients treated aesthetically complained of headaches afterwards, in some cases lasting for weeks.  They replied by saying that they had not heard of this before!  How strange, given that this is one of the commonest side effects reported in nearly all aesthetic trials and tests of the products.

More to follow!

Enter supporting content here

Toxin Science Limited
Wrexham, UK